GPT and metabolic dysfunction-associated steatotic liver disease: As shown in Supplementary Table 1, patients with NAFLD displayed high blood NEFA, glucose, insulin, HbA1c, triglyceride (TG), alanine aminotransferase (ALT), aspartate transaminase (AST) and gamma-glutamyl transpeptidase (γ-GT) levels.